Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 66.51% vs 10.00% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 227.77% vs -45.91% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 259.42% vs 22.47% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 25.22% vs -20.14% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Kilitch Drugs With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 66.51% vs 10.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 46.33% vs 36.61% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 227.77% vs -45.91% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 39.62% vs 189.69% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 259.42% vs 22.47% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 51.64% vs 106.21% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 25.22% vs -20.14% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -10.00% vs 21.21% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






